Abstract
Quinolone antibacterial agents were first introduced into the clinical environment in the early 1960s. The first qumolone to be clinically used was nalidixic acid, which was used for the treatment of enteric and urinary tract infections. As a result of increased clinical resistance to this drug, its use has declined. However, the development of other chemically related antimicrobials with activities approaching one thousand times that of nalidixic acid has meant that bacteria resistant to this early nonfluormated quinolone are susceptible to the action of the newer fluoroquinolones. The fluoroquinolones, such as ciprofloxacin and ofloxacin, have proved to be potent antimicrobials and are used throughout the world in the treatment of bacterial infections, ranging from urinary tract infections to life-threatening septicemia. The clinical success of these agents can be attributed to their broad spectrum of activity, unique mechanism of action, good tissue distribution, and absorption from the gastrointestinal tract after oral admmistration (1).
Keywords
- Nalidixic Acid
- Outer Membrane Protein
- Quinolone Resistance
- Single Stranded Conformational Polymorphism
- gyrB Gene
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Smith, J. T. and Lewin, C. S. (1988) Chemistry and mechanisms of action of thequinolone antibacterials. in The Quinolones, (Andriole, V.T., ed.), Academic, pp. 23–82.
Hallett, P. and Maxwell, A. (1991) Novel quinolone resistance mutations of theEscherichia coli DNA gyrase A protein: enzymatic analysis of the mutant proteins. Antimicrob. Agents Chemother. 35, 335–340.
Wiedemann, B. and Heisig, P. (1994) Mechanisms of quinolone resistance. infection 22, S73–S79.
Willmott, C. J. R. and Maxwell, A. (1993) A single point mutation in the DNAgyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNAcomplex. Antimicrob. Agents Chemother. 37, 126–127.
Hayes, M. V. (1995) Beta lactam and quinolone resistance in Aeromonas spp. PhD thesis. Edinburgh University.
Yoshida, H., Kojima, T., Yamagishi, J., and Nakamura, S. (1988) Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol. Gen. Genet. 211, 1–7.
Yoshida, H., Bogaki, M., Nakamura, M., and Nakamura, S. (1990) Quinoloneresistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.Antimicrob. Agents Chemother. 34, 1271–1272.
Heisig, P., Schedletzky, H., and Faikensteinpaul, H. (1993) Mutations in the gyrAgene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.Antimicrob. Agents Chemother. 37, 696–701.
Oram, M. and Fisher, L. M. (199L) 4-Quinolone resistance mutations in the DNA gyrase of Escherichia coli clinical isolates identified by using the polymerasechain reaction. Antimicrob. Agents Chemother. 35, 387–389.
Yamagishi, J, Yoshlda, H., Yamayoshi, M, and Nakamura, S (1986) Nalidixicacid-resistant mutations of the gyrB gene of Escherichia coil Mol Gen Genet 204, 367–373
Kurelshl, A., Diver, J. M., Beckthold, B., Schollaardt, T., and Bryan, L. E(1994) Cloning and nucleotide sequence of Pseudomonas aeruginosa DNA gyrase gyrAgene from stram PA01 and quinolone-resistant chmcal isolates AntimicrobAgents Chemother 38, 1944–1952
Deguchi, T., Yasuda, M., Asano, M, Tada, K., Iwata, H, Komeda, H., Ezalu, T, Salto, I, and Kawada, Y (1995) DNA gyrase mutations in qumolone-resistant clinical isolates of Neisseria gonorrhoeae Antimicrob Agents Chemother 39, 561–563.
Moore, R.A., Beckthold, B, Wong, S., Kurelshl, A, and Bryan, L E. (1995) Nucleotide sequence of the gyrA gene and characterization of ciprofloxacin-resistant mutants of Helicobacter pylori. Antimicrob Agents Chemother 39, 107–111.
Sreedharan, S., Oram, M., Jensen, B., Peterson, L. R., and Fisher, L. M. (1990) DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcusaureus: close similarity with quinolone resistance mutations in Escherichia coli J Bacteriol 172, 7260–7262
Goswitz, J. J, Willard, K. E, Fasching, C. E, and Peterson, L R. (1992) Detectionof gyrA gene mutations associated with ciprofloxacin resistance in meticilin-resistant Staphylococcus aureus analysis by polymerase chain reaction and automated direct DNA sequencing. Antimicrob Agents Chemother. 36, 1166–1169
Tanaka, M, Zhang, Y. X, Ishida, H., Akasaka, T, Sato, K, and Hayakawa, I.(1995) Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China J Med Microbiol 42, 214–219
Wang, Y, Huang, W. M, and Taylor, D. E (1993) Cloning and nucleotide sequence of the Campylobacter jejuni gyrA gene and characterization of qumolone resistance mutations. Antimicrob Agents Chemother 37, 457–463
Cambau, E, Sougakoff, W., and Jarlier, V. (1994) Amplification and nucleotide sequence of the quinolone resistance-determining region in the gyrA gene of mycobacterla FEMS Microbiol Lett 116, 49–54
Revel, V., Cambau, E, Jarlier, V, and Sougakoff, W. (1994) Characterisation ofmutations in Mycobacterium smegmatis involved in resistance to fluoroqumolones Antimicrob Agents Chemother 38, 1991–1996.
Cambau, E., Sougakoff, W, Besson, M, Truffotpernot, C, Grosset, J., and Jarlier, V. (1994) Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin J Infect. Dis 170, 479–483.
Reyna, F, Huesca, M, Gonzalez, V, and Fuchs, L Y (1995) Salmonella typhimurium gvrA mutations associated with fluoroquinolone resistance Antimicrob Agents Chemother 39, 162l–1623
Vila, J., Rmz, J, Goni, P, Marcos, A., and Deanta, T J. (1995) Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannu Antimicrob Agents Chemother 39, 1201–1203.
Oppegaard, H and Sorum, H. (1994) gyrA mutations in quinolone-resistant isolates of the fish pathogen Aeromonas salmonicida Antimicrob Agents Chemother 38, 2460–2464.
Khodursky, A. B, Zechiedrich, E L, and Cozzarelli, N. R(1995) Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl. Acad. Sci. USA 92, 11,801–11,805.
Deguchi, T., Yasuda, M., Nakano, M., Ozeki, S., Ezaki, T., Saito, I., and Kawada, Y. (1996) Qumolone-resistant Neisseria gonorrhoeue: Correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles Antimicrob Agents Chemother.40, 1020–1023.
Vila, J., RUIZ, J., Gem, P., and Deanta, M. T. J. (1996) Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother 40, 491–493.
Heisig, P. (1996) Genetic evidence for a role of parC mutations in developmentof high-level fluoroquinolone resistance in Escherichia coli Antimicrob Agents Chemother 40, 879–885
Hirai, K, Aoyama, H, Irikura, T, Iyobe, S, and Mitsuhashi, S (1986) Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli. Antimicrob Agents Chemother 29, 535–538.
Hirai, K., Aoyama, H, Suzue, S, Irikura, T, Iyobe, S, and Mitsuhashi, S (1986) Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12. Antimicrob Agents Chemother 30, 248–253.
Sanders, C. C., Sanders, W. E., Goermg, R. V., and Werner, V. (1984) Selection of multiple antibiotic resistance by Quinolones, Beta-lactams and Ammoglycosides with special reference to cross-resistance between unrelated drug classes Antimicrob Agents Chemother 26, 797–801.
Gutmann, L, Williamson, R., Moreau, N., Kitzis, M-D, Collatz, E, Acar, J F, and Goldstein, F. W. (1985) Cross-resistance to nalidixic acid, trimethoprim and chloramphenicol associated with alterations in outer membrane proteins of Klebstella, Enterobacter and Serratia. J Infect Dis. 151, 501–507.
Hirai, K., Kuzue, S, Irikura, T, Iyobe, S, and Mitsuhashi, S (1987) Mutations producing resistance to norfloxacin in Pseudomonas aerugtnosa. Antimicrob Agents Chemother 31, 582–586
Inoue, Y., Sato, K., FuJii, T., Hirai, K., Inoue, M., Iyobe, S., and Mitsuhashi, S (1987) Some properties of subunits of DNA gyrase fromPseudomonas aeruginosa PA01 and its nahdtxic acid-resistant mutant J Bacterial.169, 2322–2325.
Ishii, H., Sato, K., Hoshino, K., Sato, M., Yamaguchi, A., Sawai, T., and Osada, Y (1991) Active efflux of ofloxacin by a highly quinolone-resistant strain of Proteus vulgaris J. Antimicrob Chemother 28, 827–836.
Aoyama, H., Sato, K., FuJii, T., Fujimaki, K, Inoue, M, and Mitsuhashi, S. (1988) Purification of Citrobacter freundii DNA gyrase and inhibition by quinolones.Antimicrob. Agents Chemother 32, 104–109.
Moniot-Ville, N., Guibert, J., Moreau, N., Acar, J. F., Collatz, E., and Gutmann, L (1991) Mechanisms of quniolone resistance in a clinical isolate of Escherichiacoli’ highly resistant to fluoroquinolones but susceptible to nalidixic acid Antimicrob. Agents Chemother.35, 519–523.
Kato, N., Miyauchi, M, Muto, Y., Watanabe, K, and Ueno, K (1988) Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistanceto beta-lactam antibiotic Antimicrob Agents Chemother 32, 1437,1438.
Cohen, S P, McMurray, L M., Hooper, D. C, Wolfson, J S, and Levy, S B (1989) Cross resistance to fluoroquinolones in multiple-antibiotic-resistanct (Mar) Escherichia coli selected by tetracycline or chloramphenicol Decreased drug accumulation associated with membrane changes in addition to OmpF reduction Antimicrob Agents Chemother 33, 1318–1325
Chapman, J S., Bertasso, A, and Georgopapadakou, N. H (1989) Fleroxacm resistance in Escherichia coli. Antimicrob Agents Chemother 33, 239–241.
Bedard, J, Chamberland, S, Wong, S, Schollaardt, T, and Bryan, L E (1989) Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa and Alcaligenes faecalis to ctprofloxacin Antimicrob Agents Chemother 33, 1457–1464
Zhanel, G G, Karlowsky, J A., Saunders, M H, Davidson, R J, Hoban, D J, Hancock, R. E W., Mclean, I., and Nicolle, L. E (1995) Development of muliple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones. Antimicrob Agents Chemother 39, 489–495
Kaatz G W and Seo S M (1995) Inducible NorA-mediated multidrug resistance in Staphylococcus aureus Antimicrob Agents Chemother 39 2650–265
Yamamoto, S. and Harayama, S(1996) Phylogenetic analysis of Acinetobacter strains based on the nucleotide sequences of gyrB genes and on the amino acid sequences of then products Int J Syst Bacteriol 46, 506–511
Lehn, W, Stowerhoffman, J, Kott, T., Strassner, C, Wagner, H., Kronke, M., and Schnelderbrachert, W. (1996) Charactertsatron of climcal isolates of E.coli showing high levels of fluoroquiolone resistance. J Clin Microbol 34, 597–602
Oethinger, M., Conrad, S., Kattel, K, Cometta, A, Bille, J., Klotz, G., Glauser, M P, Marre, R, and Kern, W V (1996) Molecular epidemiology of fluroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centres. J Clin Microbiol 40, 387–392.
Sambrook, J, Fritsch, E. F, and Maniatis, T (1989) Molecular Cloning A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York
Heisig, P (1993) High-level fluoroquinolone resistance in a Salmonella typhimurium isolate due to alterations in both gyrA and gyrB genes J Antimicrob Chemother 32, 367–377.
Robillard, N J (1990) Broad-host-range gyrase A gene probe. Antimicrob. Agents Chemother, 34, 1889–1894
Zyskind, J W. and Bernstein, S. I (1992) Isolation and purification of E,coli and Drosophila chromosomal DNA, in Recombinant DNA Laboratory Manual, 2nd ed. (Zyskind, J. W. and Bernstein, S. I., eds.), Academic, New York, pp 12–
Del Vecchio, V G, Petroziello, J. M., Gress, M J, McCleskey, F K, Melcher, G. P., Crouch, H. K., and Lupski, J. R. (1995) Molecular genotyping of methicillin-resistant Staphylococcus aureus via fluorophore-enhanced repetitive-sequence PCR J. Clin Microbiol 33, 2141–2144.
Brown, J. C., Thomson, C J., and Amyes, S G. B. (1996) Mutations of the gyrA gene of clinical isolates of Salmonella typhtmurium and three other Salmonella spectes leading to decreased susceptibilities to 4-quinolone drugs J Antimicrob Chemother 37, 359–366.
Rahman, M, Mauff, G., Levy, J, Couturier, M., Pulverer, G., Glasdorff, N., and Butzler, J. P (1994) Detection of 4-quinolone reststance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrob Agents Chemother 38, 2488–2491
Tokue, Y, Sugano, K., Saito, D, Noda, T., Ohkura, H, Shimosato, Y., and Sekiya, T (1994) Detection of novel mutations in the gyrA gene of Staphylococcus aureus by nonradioisotopic single-strand conformation polymorphism analysis and direct DNA sequencing Antimicrob Agents Chemother 38, 428–431
Korten, V, Huang, W. M, and Murray, B. E (1994) Analysis by PCR and direct DNA sequencing of gyrA mutations associated with fluoroquinolone resistance in Enterococcus faecalis Antimicrob Agents Chemother 38, 2091–2094
Yonezawa, M, Takahata, M, Matsubara, N., Watanabe, Y, and Narita, H (1995) DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aerugtnosa. Antimicrob Agents Chemother 39, 1970–1972
Brown, J C, Shanahan, P M A, Jesudason, M V, Thomson, C J, and Amyes, S G B (1996) Mutations responsible for reduced susceptibilities to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in Indta. J Antimicrob Chemother 37, 891–900
Quibell, K J (1993) Mechanisms of resistance of Pseudomonas aeruginosa to the 4-quinolones PhD thesis. Edinburgh University
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Humana Press Inc.
About this protocol
Cite this protocol
Brown, J.C., Amyes, S.G.B. (1998). Quinolone Resistance. In: Woodford, N., Johnson, A.P. (eds) Molecular Bacteriology. Methods in Molecular Medicine™, vol 15. Humana Press. https://doi.org/10.1385/0-89603-498-4:617
Download citation
DOI: https://doi.org/10.1385/0-89603-498-4:617
Publisher Name: Humana Press
Print ISBN: 978-0-89603-498-3
Online ISBN: 978-1-59259-599-0
eBook Packages: Springer Protocols